634 related articles for article (PubMed ID: 21587068)
1. The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease.
Martínez-Clemente M; Clària J; Titos E
Curr Opin Clin Nutr Metab Care; 2011 Jul; 14(4):347-53. PubMed ID: 21587068
[TBL] [Abstract][Full Text] [Related]
2. 5-lipoxygenase activating protein signals adipose tissue inflammation and lipid dysfunction in experimental obesity.
Horrillo R; González-Périz A; Martínez-Clemente M; López-Parra M; Ferré N; Titos E; Morán-Salvador E; Deulofeu R; Arroyo V; Clària J
J Immunol; 2010 Apr; 184(7):3978-87. PubMed ID: 20207999
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
4. T cell-mediated inflammation in adipose tissue does not cause insulin resistance in hyperlipidemic mice.
Sultan A; Strodthoff D; Robertson AK; Paulsson-Berne G; Fauconnier J; Parini P; Rydén M; Thierry-Mieg N; Johansson ME; Chibalin AV; Zierath JR; Arner P; Hansson GK
Circ Res; 2009 Apr; 104(8):961-8. PubMed ID: 19299644
[TBL] [Abstract][Full Text] [Related]
5. Monocyte chemotactic protein-1 and its role in insulin resistance.
Sell H; Eckel J
Curr Opin Lipidol; 2007 Jun; 18(3):258-62. PubMed ID: 17495598
[TBL] [Abstract][Full Text] [Related]
6. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
Cusi K
Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
[TBL] [Abstract][Full Text] [Related]
7. Adipose tissue dysfunction in obesity.
Blüher M
Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
[TBL] [Abstract][Full Text] [Related]
8. Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?
Caldwell SH; Ikura Y; Iezzoni JC; Liu Z
J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S11-9. PubMed ID: 17567458
[TBL] [Abstract][Full Text] [Related]
9. Active spice-derived components can inhibit inflammatory responses of adipose tissue in obesity by suppressing inflammatory actions of macrophages and release of monocyte chemoattractant protein-1 from adipocytes.
Woo HM; Kang JH; Kawada T; Yoo H; Sung MK; Yu R
Life Sci; 2007 Feb; 80(10):926-31. PubMed ID: 17196622
[TBL] [Abstract][Full Text] [Related]
10. Adipose tissue inflammation in obesity and metabolic syndrome.
Nishimura S; Manabe I; Nagai R
Discov Med; 2009 Aug; 8(41):55-60. PubMed ID: 19788868
[TBL] [Abstract][Full Text] [Related]
11. A fresh look at NASH pathogenesis. Part 1: the metabolic movers.
Larter CZ; Chitturi S; Heydet D; Farrell GC
J Gastroenterol Hepatol; 2010 Apr; 25(4):672-90. PubMed ID: 20492324
[TBL] [Abstract][Full Text] [Related]
12. Liver fat in the pathogenesis of insulin resistance and type 2 diabetes.
Yki-Järvinen H
Dig Dis; 2010; 28(1):203-9. PubMed ID: 20460912
[TBL] [Abstract][Full Text] [Related]
13. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.
Parekh S; Anania FA
Gastroenterology; 2007 May; 132(6):2191-207. PubMed ID: 17498512
[TBL] [Abstract][Full Text] [Related]
14. A novel pathway to the manifestations of metabolic syndrome.
Sonnenberg GE; Krakower GR; Kissebah AH
Obes Res; 2004 Feb; 12(2):180-6. PubMed ID: 14981209
[TBL] [Abstract][Full Text] [Related]
15. Chemotactic cytokines, obesity and type 2 diabetes: in vivo and in vitro evidence for a possible causal correlation?
Sell H; Eckel J
Proc Nutr Soc; 2009 Nov; 68(4):378-84. PubMed ID: 19698204
[TBL] [Abstract][Full Text] [Related]
16. Adipokines in diabetes and cardiovascular diseases.
Kralisch S; Sommer G; Deckert CM; Linke A; Bluher M; Stumvoll M; Fasshauer M
Minerva Endocrinol; 2007 Sep; 32(3):161-71. PubMed ID: 17912155
[TBL] [Abstract][Full Text] [Related]
17. 12/15-lipoxygenase products induce inflammation and impair insulin signaling in 3T3-L1 adipocytes.
Chakrabarti SK; Cole BK; Wen Y; Keller SR; Nadler JL
Obesity (Silver Spring); 2009 Sep; 17(9):1657-63. PubMed ID: 19521344
[TBL] [Abstract][Full Text] [Related]
18. Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat.
Davis JE; Gabler NK; Walker-Daniels J; Spurlock ME
Obesity (Silver Spring); 2008 Jun; 16(6):1248-55. PubMed ID: 18421279
[TBL] [Abstract][Full Text] [Related]
19. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome.
Maury E; Brichard SM
Mol Cell Endocrinol; 2010 Jan; 314(1):1-16. PubMed ID: 19682539
[TBL] [Abstract][Full Text] [Related]
20. Adipose tissue as an endocrine organ.
Galic S; Oakhill JS; Steinberg GR
Mol Cell Endocrinol; 2010 Mar; 316(2):129-39. PubMed ID: 19723556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
